A new test to quickly detect Babesia microti and diagnose Lyme disease.
A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease.
This study is working on a quick and easy test that uses a small blood sample to help doctors accurately detect the Babesia microti parasite and Lyme disease, making it especially helpful for people who are at higher risk for these tick-borne illnesses.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biopeptides, INC. NIH-funded |
| Lab location | 1 site (Ridgefield, UNITED STATES) |
| Project ID | NIH-10918786 on NIH RePORTER |
What this research studies
This research focuses on developing a point-of-care vertical flow assay that can directly detect the Babesia microti parasite and diagnose Lyme disease. The approach aims to provide rapid and accurate testing for these tick-borne diseases, which can often be misdiagnosed or go undetected. By utilizing a simple blood sample, the assay seeks to improve patient outcomes through timely diagnosis and treatment. The research will explore the effectiveness of this assay in various patient populations, particularly those at higher risk.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been exposed to ticks and are experiencing symptoms related to babesiosis or Lyme disease.
Not a fit: Patients who have already been diagnosed and treated for Babesia microti or Lyme disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses of Babesia microti infections and Lyme disease, improving treatment outcomes for patients.
How similar studies have performed: Other research has shown promise in developing rapid diagnostic tests for tick-borne diseases, indicating that this approach has potential for success.
Where this research is happening
Ridgefield, UNITED STATES
- Biopeptides, INC. — Ridgefield, United States (Active)
Researchers
- Principal investigator: Dattwyler, Raymond James — Biopeptides, INC.
- Study coordinator: Dattwyler, Raymond James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.